Form 4: Walgreens Boots Alliance Sells Additional Cencora Shares, Reducing Stake Through Block Sale and Early Settlement of Forward Sale Contracts

Walgreens Boots Alliance continues to reduce its stake in Cencora through a block sale and early settlement of forward sale contracts, generating proceeds and further unwinding its investment.

Summary

• Walgreens Boots Alliance, Inc. (WBA) has reduced its holdings in Cencora, Inc. (COR) through a block sale and early settlement of existing variable pre-paid forward sale contracts.
• On February 6, 2025, Walgreens Boots Alliance Holdings LLC (a subsidiary of WBA) executed a block sale of 1,081,885 shares of Cencora common stock at a price of $244.51 per share.
• The company also entered into early settlement agreements with unaffiliated financial institutions to settle existing variable pre-paid forward sale contracts.
• These contracts, initiated on August 3, 2023, and November 9, 2023, obligated Walgreens Boots Alliance Holdings LLC to deliver up to 5,250,000 and 2,160,000 shares of Cencora common stock, respectively.
• The early settlement involved delivering shares of common stock and making net cash payments totaling $9,542,637.31 and $10,433,585.66 to the financial institutions.
• Following these transactions, Walgreens Boots Alliance directly owns 12,570,000 shares and indirectly owns 18,898,115 shares of Cencora.
• The forward sale contracts obligated Counterparty to deliver to the financial institutions in the aggregate up to 5,250,000 shares of common stock and 2,160,000 shares of Common Stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document describes a planned divestiture, which is neither inherently positive nor negative. The financial impact is not explicitly stated, making it difficult to assess the overall sentiment.

Positives

• The block sale and early settlement of forward sale contracts generate proceeds for Walgreens Boots Alliance.
• The transactions allow Walgreens Boots Alliance to further reduce its stake in Cencora.

Future Outlook

The document does not explicitly provide a future outlook, but it implies a continued reduction of Walgreens Boots Alliance's stake in Cencora.

Industry Context

Walgreens Boots Alliance's continued divestiture of Cencora shares reflects a strategic shift in its investment portfolio, potentially focusing on core business operations or other investment opportunities. This is not uncommon for large corporations to re-balance their portfolios.

Comparison to Industry Standards

• It is difficult to compare this transaction directly to industry standards without knowing the specific strategic rationale behind Walgreens Boots Alliance's divestiture.
• However, large corporations frequently adjust their investment portfolios, and divestitures of non-core assets are a common practice.
• Comparable companies like CVS Health or UnitedHealth Group also periodically review and adjust their investment portfolios based on strategic priorities.

Stakeholder Impact

• Shareholders of Walgreens Boots Alliance may see this as a positive move if the proceeds from the share sale are used to improve the company's financial position or invest in growth opportunities.
• Cencora shareholders may experience some volatility in the short term due to the large block sale, but the long-term impact is likely to be minimal.

Key Dates

Keywords

Cencora, Walgreens Boots Alliance, Share Sale, Block Trade, Forward Sale Contracts, Settlement Agreements, Divestiture